Medical Condition News

RSS

nContact receives FDA clearance for EPi-Sense cardiac ablation device

nContact, Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's modifications to its VisiTrax cardiac ablation device, EPi-Sense, now with embedded sensing capability.

18 Jan 2013

RSAS honors Feinstein Institute scientist with Crafoord Prize for genetic research on arthritis

The Royal Swedish Academy of Sciences announced today that Peter K. Gregersen , MD, a scientist at The Feinstein Institute for Medical Research, will receive the prestigious Crafoord Prize for his genetic research in the area rheumatoid arthritis.

18 Jan 2013

Study finds key association between Kallikrein 6 and malignant tumors

One of the most common types of brain tumors in adults, glioblastoma multiforme, is one of the most devastating. Even with recent advances in surgery, radiation and chemotherapy, the aggressive and invasive tumors become resistant to treatment, and median survival of patients is only about 15 months. In a study published in Neuro-Oncology, researchers at Mayo Clinic identify an important association between the naturally occurring enzyme Kallikrein 6, also known as KLK6, and the malignant tumors.

18 Jan 2013

Simple interventions can reduce amputations in diabetic patients by more than 50%

Every 30 seconds somebody in the world is amputated as a consequence of foot complication due to diabetes. A new study at Sahlgrenska Academy, University of Gothenburg, Sweden, confirmes that shoe inserts, podiatry, regular checkups and other simple interventions can reduce the number of amputations by more than 50%.

18 Jan 2013

Early life exposure to gut microbes protects against autoimmune disease

Early life exposure to normal bacteria of the GI tract (gut microbes) protects against autoimmune disease in mice, according to research published on-line in the January 17 edition of Science. The study may also have uncovered reasons why females are at greater risk of autoimmune diseases such as multiple sclerosis, rheumatoid arthritis, and lupus compared to males.

18 Jan 2013

Octapharma receives FDA approval for Octaplas to treat blood clotting disorders

The U.S. Food and Drug Administration today approved Octaplas, a pooled plasma (human) blood product for the replacement of clotting proteins (coagulation factors) in certain medical conditions where patients have insufficient levels.

18 Jan 2013

Atrial fibrillation increases risk of kidney failure in people with CKD

Many people who suffer from chronic kidney disease progressively lose their kidney function over time and eventually develop a condition called end-stage renal disease - the complete failure of the kidneys - placing them in need of lifelong dialysis or a kidney transplant.

18 Jan 2013

Longer looks: 'Bad suga' damages a neighborhood; A nurse's dying gift; Are ethical guidelines impeding patient care?

Bad suga' is devastating my neighborhood of North Lawndale, one of Chicago's poorest communities. Diabetes is commonly called "bad suga'" in many African American communities like the one where I grew up and live today.

18 Jan 2013

Spain approves pSivida’s ILUVIEN to treat chronic diabetic macular edema

pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, announced today that the Spanish Agency of Drugs and Medical Devices (Agencia Espanola de Medicamentos y Productos Sanitarios) granted marketing authorization to ILUVIEN for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies.

18 Jan 2013

Report: Cancer death rates decline 20% from its peak in 1991

As of 2009, the overall death rate for cancer in the United States had declined 20 percent from its peak in 1991, translating to the avoidance of approximately 1.2 million deaths from cancer, 152,900 of these in 2009 alone. These figures come from the American Cancer Society's annual Cancer Statistics report, one of the most widely-cited medical publications in the world.

17 Jan 2013

SyNAPSe® Trial by BHR Pharma deemed to have no safety issues according to DSMB

BHR Pharma, LLC announced today that the SyNAPSe® Trial's independent Data and Safety Monitoring Board (DSMB) evaluated safety data from 803 randomized patients and determined that no issues exist; therefore, the trial may continue towards its intended completion.

17 Jan 2013

FDA clears Sanovas’ Vas Zeppelin Smart Catheter to treat chronic pulmonary diseases, lung cancer

Sanovas Inc., a life science technology company developing and commercializing the next-generation of micro-invasive diagnostics, devices and drug delivery technologies, announced today that it has filed with the U.S. Food and Drug Administration for clearance of the company's Vas Zeppelin Smart Catheter for the treatment of chronic pulmonary diseases and lung cancer.

17 Jan 2013

New combination of neural imaging methods discovers brain's ability to adapt to injury

For the first time, scientists at Carnegie Mellon University's Center for Cognitive Brain Imaging (CCBI) have used a new combination of neural imaging methods to discover exactly how the human brain adapts to injury.

17 Jan 2013

Study identifies genes for central corneal thickness that may cause eye conditions

Scientists at Singapore Eye Research Institute and A*STAR's Genome Institute of Singapore have succeeded in identifying genes for central corneal thickness that may cause potentially blinding eye conditions. These eye conditions include glaucoma, as well as the progressive thinning of the cornea, which may eventually lead to a need for corneal transplantation.

17 Jan 2013

ELTD1 biomarker may help diagnose glioma

Researchers using sophisticated genetic testing techniques have identified a promising new biomarker for diagnosis of glioma—the most common type of malignant brain tumor, reports the January issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

17 Jan 2013

Athletes with concussions in early adulthood may be at increased risk of depression as they age

National Football League (NFL) players may be at increased risk of depression as they age due to brain damage resulting from concussions, according to two studies released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.

17 Jan 2013

MPL vaccine can stimulate brain's natural defense mechanisms in people with AD

A team of researchers from Universit- Laval, CHU de Qu-bec, and pharmaceutical firm GlaxoSmithKline (GSK) has discovered a way to stimulate the brain's natural defense mechanisms in people with Alzheimer's disease.

17 Jan 2013

Jersey Shore University Medical Center launches Meridian Executive Health program

Jersey Shore University Medical Center announces the launch of the Meridian Executive Health program, a health care pilot initiative designed for busy individuals whose schedule demands a streamlined but high quality experience.

17 Jan 2013

Researchers identify potential sources of medicines derived from plants against diabetes

A group of researchers from the university's School of Science, led by Dr Solomon Habtemariam, believe they have identified potential sources of medicines derived from plants which may have fewer adverse side-effects for diabetes sufferers.

17 Jan 2013

Women who have migraine with aura more likely to develop major cardiovascular events

Women who have migraines with aura, which are often visual disturbances such as flashing lights, may be more likely to have problems with their heart and blood vessels, and those on newer contraceptives may be at higher risk for blood clots, according to two studies released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.

17 Jan 2013

Medical Condition News

nContact receives FDA clearance for EPi-Sense cardiac ablation device

RSAS honors Feinstein Institute scientist with Crafoord Prize for genetic research on arthritis

Study finds key association between Kallikrein 6 and malignant tumors

Simple interventions can reduce amputations in diabetic patients by more than 50%

Early life exposure to gut microbes protects against autoimmune disease

Octapharma receives FDA approval for Octaplas to treat blood clotting disorders

Atrial fibrillation increases risk of kidney failure in people with CKD

Longer looks: 'Bad suga' damages a neighborhood; A nurse's dying gift; Are ethical guidelines impeding patient care?

Spain approves pSivida’s ILUVIEN to treat chronic diabetic macular edema

Report: Cancer death rates decline 20% from its peak in 1991

SyNAPSe® Trial by BHR Pharma deemed to have no safety issues according to DSMB

FDA clears Sanovas’ Vas Zeppelin Smart Catheter to treat chronic pulmonary diseases, lung cancer

New combination of neural imaging methods discovers brain's ability to adapt to injury

Study identifies genes for central corneal thickness that may cause eye conditions

ELTD1 biomarker may help diagnose glioma

Athletes with concussions in early adulthood may be at increased risk of depression as they age

MPL vaccine can stimulate brain's natural defense mechanisms in people with AD

Jersey Shore University Medical Center launches Meridian Executive Health program

Researchers identify potential sources of medicines derived from plants against diabetes

Women who have migraine with aura more likely to develop major cardiovascular events

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News